JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Udesky, J. O.
Right arrow Articles by Flood, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Udesky, J. O.
Right arrow Articles by Flood, P.
Related Collections
Right arrow Pharmacology

Anesth Analg 2005;101:407-411
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000155291.81338.90


ANESTHETIC PHARMACOLOGY

The Role of Nicotinic Inhibition in Ketamine-Induced Behavior

Julia O. Udesky, Nicole Z. Spence, Ron Achiel, Chrisitane Lee, and Pamela Flood, MD

Department of Anesthesiology, Columbia University, New York, New York

Address correspondence and reprint requests to Pamela Flood, MD, Department of Anesthesiology, College of Physicians & Surgeons of Columbia University, 630 West 168th Street, New York, New York 10032. Address e-mail to pdf3{at}columbia.edu.

Several anesthetic drugs are nicotinic antagonists at or below levels used for anesthesia, including ketamine and volatile anesthetics. In contrast, propofol does not inhibit nicotinic receptors. To determine the potential behavioral ramifications of nicotinic inhibition by ketamine, we determined the doses of ketamine required to induce immobility, impair the righting reflex, and cause analgesia in the absence and presence of several nicotinic ligands. Propofol was used as a control in similar experiments. When used as a sole anesthetic drug, 383 ± 22 mg/kg ketamine intraperitoneally (IP) was required for immobility and 180 ± 17 mg/kg IP impaired righting reflex. Propofol, 371 ± 34 mg/kg IP, induced immobility whereas 199 mg/kg IP inhibited the righting reflex. Nicotinic antagonists had no effect on the dose of propofol or ketamine required for either end-point. When nociceptive responses were tested at subhypnotic doses, no pronociceptive or antinociceptive phase was identified for propofol, whereas analgesia was induced at ketamine doses larger than 60 mg/kg IP. The broad-spectrum nicotinic antagonist mecamylamine enhanced the analgesic action of ketamine. These findings are different than those seen with volatile anesthetics, where nicotinic inhibition is thought to be responsible for a pronociceptive action. Such a phase is possibly obscured by analgesia induced as a result of N-methyl-d-aspartic acid antagonism by ketamine.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
S. S. Cheng, J. Yeh, and P. Flood
Anesthesia Matters: Patients Anesthetized with Propofol Have Less Postoperative Pain than Those Anesthetized with Isoflurane
Anesth. Analg., January 1, 2008; 106(1): 264 - 269.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2005 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.